Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Diagnosis

Baseline total lesion glycolysis by positron emission tomography/ computed tomography as a best prognostic parameter for patients with primary thyroid lymphoma

Yang Fan, Zhi Yang and Xuejuan Wang
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1373;
Yang Fan
1Peking University Cancer Hospital, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhi Yang
1Peking University Cancer Hospital, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xuejuan Wang
1Peking University Cancer Hospital, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 56 no. supplement 3 1373

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 15, 2015.

Copyright & Usage 

Author Information

  1. Yang Fan1,
  2. Zhi Yang1 and
  3. Xuejuan Wang1
  1. 1Peking University Cancer Hospital, Beijing, China

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2015 to April 2025

AbstractFullPdf
May 2015300
Jun 2015900
Jul 20151100
Sep 2015700
Oct 2015500
Nov 2015600
Dec 2015300
Jan 20164600
Feb 2016100
Mar 2016200
Jun 2016100
Jul 2016100
Aug 2016200
Sep 2016200
Oct 20161200
Nov 20162900
Dec 2016200
Jan 2017300
Feb 2017100
Mar 2017400
Apr 2017300
May 2017100
Jun 2017600
Jul 2017300
Aug 2017200
Sep 2017400
Nov 2017300
Dec 2017100
Jan 2018100
Mar 2018200
Apr 2018100
Nov 2018100
Dec 2018700
Jan 2019100
Jul 2019100
Oct 2019100
Nov 2019100
Feb 2020100
Mar 2020100
May 2020100
Sep 2020100
Oct 2020100
Nov 2020100
Dec 2020200
Jan 2021100
Feb 2021800
Mar 2021800
Apr 2021800
May 20211700
Jun 20213100
Jul 20215000
Aug 202110200
Sep 2021600
Oct 2021200
Nov 2021200
Dec 2021200
Jan 2022100
Feb 2022300
Mar 2022200
Apr 2022300
May 2022100
Jun 2022500
Jul 2022200
Aug 2022200
Sep 2022100
Dec 2022100
Feb 2023100
Mar 2023200
Apr 2023200
May 2023200
Jun 2023400
Jul 2023100
Aug 2023200
Sep 2023300
Oct 2023200
Nov 2023200
Dec 2023100
Jan 2024400
Feb 2024100
Mar 2024100
Apr 2024300
May 2024600
Jun 2024300
Jul 2024700
Aug 2024200
Sep 2024200
Oct 2024600
Nov 2024300
Dec 2024100
Feb 2025100
Mar 2025100
Apr 2025400
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 56, Issue supplement 3
May 1, 2015
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Baseline total lesion glycolysis by positron emission tomography/ computed tomography as a best prognostic parameter for patients with primary thyroid lymphoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Baseline total lesion glycolysis by positron emission tomography/ computed tomography as a best prognostic parameter for patients with primary thyroid lymphoma
Yang Fan, Zhi Yang, Xuejuan Wang
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1373;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Baseline total lesion glycolysis by positron emission tomography/ computed tomography as a best prognostic parameter for patients with primary thyroid lymphoma
Yang Fan, Zhi Yang, Xuejuan Wang
Journal of Nuclear Medicine May 2015, 56 (supplement 3) 1373;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Diagnosis

  • High detection performance and accurate staging of adrenal glands using state-of-the-art PET/CT
  • A regression model to predict tumor cellularity in patients with prostate cancer and low FDG uptake
  • Prediction of Response to Neoadjuvant Chemotherapy in Osteosarcoma using Dual-phase 18F-FDG PET/CT
Show more Oncology: Clinical Diagnosis

MTA I: Leukemia/Lymphoma/Myeloma Posters

  • Role of initial, interim, and post-treatment F-18 FDG PET/CT in prognostication of clinically diagnosed extranodal lymphoma
  • FDG avidity of mediastinum and liver on sequential PET/CT scans in NKT cell lymphoma nasal type
  • F-18 FDG PET/CT for the diagnosis of lymphoma and analysis on misdiagnosis
Show more MTA I: Leukemia/Lymphoma/Myeloma Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire